Real-time enrollment status for this her2-positive breast carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:23 PM UTC
| NCT Number | NCT06557057 |
| Recruiting Status | Recruiting |
| Condition | HER2-Positive Breast Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 66 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | March 31, 2026 (Mar 31, 2026) |
As of July 13, 2026: Clinical trial NCT06557057 is currently recruiting participants. This clinical trial study for her2-positive breast carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06557057 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06557057 was last updated Mar 31, 2026 (March 31, 2026). HelloStudys verifies this status automatically.